Here's Why You Should Retain Glaukos (GKOS) Stock for Now
Glaukos (GKOS) Gains Nearly 25% YTD: What's Driving the Rally?
Glaukos (GKOS) Hits 52-Week High: What's Driving the Stock?
Glaukos' (GKOS) iDose TR Receives Permanent J- Code From CMS
Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Glaukos (GKOS) and Omnicell (OMCL)
Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
Glaukos (GKOS) Down 4.3% Since Last Earnings Report: Can It Rebound?
Glaukos (GKOS) Down 4.3% Since Last Earnings Report: Can It Rebound?
Here's Why You Should Retain Glaukos (GKOS) Stock for Now
Here's Why You Should Retain Glaukos (GKOS) Stock for Now
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.